UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.833

Sortiert nach

Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

Annals of oncology, 2020-09, Vol.31 (9), p.1216-1222

2020

Volltextzugriff (PDF)

Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial

Annals of oncology, 2021-12, Vol.32 (12), p.1590-1596

2021

Volltextzugriff (PDF)

Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy

Annals of oncology, 2015-01, Vol.26 (1), p.95-100

2015

Volltextzugriff (PDF)

The prognostic impact of age in patients with triple-negative breast cancer

Breast cancer research and treatment, 2013-04, Vol.138 (2), p.591-599

2013

Volltextzugriff (PDF)

Influence of PIK3CA mutations on breast cancer proliferation, lymphocyte infiltration and clinical outcome: Pooled analysis of 484 patients from three prospective multicentre GBG trials

Annals of oncology, 2019-05, Vol.30, p.iii6-iii6

2019

Volltextzugriff (PDF)

Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy

Annals of oncology, 2021-04, Vol.32 (4), p.500-511

2021

Volltextzugriff (PDF)

Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer

Journal of cancer research and clinical oncology, 2021-05, Vol.147 (5), p.1421-1430

2021

Volltextzugriff (PDF)

Predictive factors for conversion to laparotomy in women undergoing laparoscopic hysterectomy. A re-evaluation of clinicopathological factors in the era of minimally invasive gynaecology

Facts, views & vision in ObGyn, 2024-06, Vol.16 (2), p.185-193

2024

Volltextzugriff (PDF)

Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer

Breast cancer research and treatment, 2009-02, Vol.113 (3), p.457-466

2009

Volltextzugriff (PDF)

Evaluation of the MammaTyper® as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes

Annals of oncology, 2018-10, Vol.29, p.viii73-viii73

2018

Volltextzugriff (PDF)

Validation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)

Annals of oncology, 2018-10, Vol.29, p.viii53-viii53

2018

Volltextzugriff (PDF)

Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab: a translational project in the neoadjuvant GeparQuinto trial

British journal of cancer, 2012-09, Vol.107 (6), p.956-960

2012

Volltextzugriff (PDF)

Methylation of estrogen receptor β promoter correlates with loss of ER-β expression in mammary carcinoma and is an early indication marker in premalignant lesions

Endocrine-related cancer, 2005-12, Vol.12 (4), p.903-916

2005

Volltextzugriff (PDF)

BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial

Breast cancer research and treatment, 2017-12, Vol.166 (3), p.775-785

2017

Volltextzugriff (PDF)

Clinical relevance of the putative stem cell marker p63 in breast cancer

Breast cancer research and treatment, 2010-08, Vol.122 (3), p.765-775

2010

Volltextzugriff (PDF)

Molecular Markers as Prognostic Factors in DCIS and Small Invasive Breast Cancers

Geburtshilfe und Frauenheilkunde, 2014-11, Vol.74 (11), p.1016-1022

2014

Volltextzugriff (PDF)

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer

British journal of cancer, 2012-11, Vol.107 (11), p.1892-1900

2012

Volltextzugriff (PDF)

Prognostic impact of thymidine phosphorylase expression in breast cancer – Comparison of microarray and immunohistochemical data

European journal of cancer (1990), 2010-02, Vol.46 (3), p.549-557

2010

Volltextzugriff (PDF)

Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer

Climacteric : the journal of the International Menopause Society, 2009-12, Vol.12 (6), p.502-513

2009

Volltextzugriff (PDF)

“Stem cell like” breast cancers—A model for the identification of new prognostic/predictive markers in endocrine responsive breast cancer exemplified by Plexin B1

European journal of obstetrics & gynecology and reproductive biology, 2008-07, Vol.139 (1), p.11-15

2008

Volltextzugriff (PDF)

Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response

Breast (Edinburgh), 2007-02, Vol.16 (1), p.86-93

2007

Volltextzugriff (PDF)

The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial

Breast (Edinburgh), 2007-06, Vol.16 (3), p.235-240

2007

Volltextzugriff (PDF)

Differentially expressed genes of reprogrammed human pluripotent stem cells in breast cancer

European journal of cancer (1990), 2008-09, Vol.44 (13), p.1789-1792

2008

Volltextzugriff (PDF)

Induction and Down-Regulation of PLK, a Human Serine/Threonine Kinase Expressed in Proliferating Cells and Tumors

Proceedings of the National Academy of Sciences - PNAS, 1994-03, Vol.91 (5), p.1736-1740

1994

Volltextzugriff (PDF)

1 – 25 von 2.833

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.174)
Mit Volltextzugriff
(2.444)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(1.188)
Ingenta
(971)
MEDLINE
(699)
Ovid SocietyJournals and Single Titles
(612)
NUS Single-Journal Subscriptions
(484)
IngentaConnect Journals
(437)
Elsevier ScienceDirect Journals Complete
(424)
Wiley Online Library - AutoHoldings Journals
(335)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(223)
SpringerLINK Journals
(223)
Wiley Online Library
(162)
JSTOR
(154)
IEEE Xplore
(145)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(138)
Nexis Uni
(114)
Access via Business Source (EBSCOhost)
(111)
Taylor & Francis
(91)
Access via Taylor & Francis
(88)
Taylor & Francis Online
(87)
Nature_系列刊
(82)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial

Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy

The prognostic impact of age in patients with triple-negative breast cancer

Influence of PIK3CA mutations on breast cancer proliferation, lymphocyte infiltration and clinical outcome: Pooled analysis of 484 patients from three prospective multicentre GBG trials

Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy

Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer

Predictive factors for conversion to laparotomy in women undergoing laparoscopic hysterectomy. A re-evaluation of clinicopathological factors in the era of minimally invasive gynaecology

Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer

Evaluation of the MammaTyper® as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes

Validation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)

Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab: a translational project in the neoadjuvant GeparQuinto trial

Methylation of estrogen receptor β promoter correlates with loss of ER-β expression in mammary carcinoma and is an early indication marker in premalignant lesions

BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial

Clinical relevance of the putative stem cell marker p63 in breast cancer

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression

Molecular Markers as Prognostic Factors in DCIS and Small Invasive Breast Cancers

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer

Prognostic impact of thymidine phosphorylase expression in breast cancer – Comparison of microarray and immunohistochemical data

Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer

“Stem cell like” breast cancers—A model for the identification of new prognostic/predictive markers in endocrine responsive breast cancer exemplified by Plexin B1

Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response

The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial

Differentially expressed genes of reprogrammed human pluripotent stem cells in breast cancer

Induction and Down-Regulation of PLK, a Human Serine/Threonine Kinase Expressed in Proliferating Cells and Tumors

Suchergebnisse filtern